您的位置:首页 > 产品中心 > 220127-57-1, 伊马替尼 甲磺酸酯
伊马替尼 甲磺酸酯
Imatinib mesilate
产品编号: | 3098385 |
规格: | European Pharmacopoeia (EP) Reference Standard |
CAS NO: | 220127-57-1 |
包装规格: |
产品类别: | 进口试剂 |
优惠价: | 立即咨询 |
产品价格查看更多规格...
产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
3098385 | 1720 |
产品别名
220127-57-1
伊马替尼 甲磺酸酯
Imatinib mesilate
CGP 57148
Genfatinib
STI-571
Imatinib Methanesulfonate
Imatinib Mesylate
4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate
Glivec
4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate
4-[(4-甲基-1-哌嗪基)甲基]-N-[4-甲基-3-[[4-(3-吡啶基)-2-嘧啶基]氨基]苯基]苯甲酰胺 甲磺酸酯
4-[(4-甲基哌嗪-1-基)甲基]-N-(4-甲基-3-{[4-(吡啶-3-基)嘧啶-2-基]氨基}苯基)苯甲酰胺 甲磺酸酯
格列卫
甲磺酸伊马替尼
基本信息
Empirical Formula【经验(实验)分子式】 | C29H31N7O · CH4O3S |
Molecular weight | 589.71 |
NACRES | NA.24 |
General description【一般描述】 | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. |
Biochem/physiol Actions【生化/生理作用】 | 甲磺酸伊马替尼是一种具有抗肿瘤活性的酪氨酸激酶抑制剂。伊马替尼能够抑制由bcr-abl致癌基因编码的Bcr-Abl激酶以及由c-kit和血小板源性生长因子受体(PDGFR)致癌基因编码的受体酪氨酸激酶。甲磺酸伊马替尼通过抑制由CML中费城染色体异常产生的Bcr-Abl酪氨酸激酶,降低了白血病CML和ALL的增殖并诱导其凋亡。 在过度表达c-kit的疾病中,如胃肠道间质瘤(GIST),通过抑制c-kit酪氨酸活性,可抑制肥大细胞和细胞增殖。 |
Other Notes【其他说明】 | Sales restrictions may apply. |
产品性质
grade【等级】 | pharmaceutical primary standard |
manufacturer/tradename | EDQM |
application(s) | pharmaceutical (small molecule) |
format【格式】 | neat |
storage temp.【储存温度】 | 2-8℃ |
InChI | 1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4) |
InChI key | YLMAHDNUQAMNNX-UHFFFAOYSA-N |
packaging【包装】 | Unit quantity: 120 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. |
安全信息
Pictograms【象形图】 | GHS08 |
Signal word【警示用语:】 | Warning |
Hazard Statements | H361d |
Precautionary Statements | P201 - P202 - P280 - P308 + P313 - P405 - P501 |
Hazard Classifications【危险分类】 | Repr. 2 |
Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
WGK | WGK 3 |